Table 6.

Adjusted healthcare costs of MBC progression and MBC progression free patients.

Cost ratios	Total costs	95% CI	OP costs	95% CI	OP drug costs	95% CI	IP costs	95% CI	IP drug costs	95% CI	ER costs	95% CI
Intercept	2,479	1,885.40 | 3,261.91	808.11	623.09 | 1048.06	179.72∗	121.58 | 265.68	3,988.32∗	2,806.56 | 5,667.68	1,027.02	539.15 | 1,956.33	193.74∗	129.60 | 289.62
Group
BCF	1.00		1.00		1.00		1.00		1.00		1.00
MBC
Progression	16.28∗	13.76–19.28	21.12∗	18.00–24.77	65.35∗	51.6–82.70	1.94∗	1.58–2.37	5.03∗	3.46–7.31	2.64∗	2.13–3.27
Progression free	2.71∗	2.54–2.88	2.88∗	2.72–3.06	4.31∗	3.95–4.71	1.51∗	1.34–1.70	1.61∗	1.30–2.00	1.47∗	1.33–1.62
BC	8.87∗	8.53–9.22	8.95∗	8.63–9.29	15.13∗	14.3–16.01	1.69∗	1.58–1.81	4.47∗	3.90–5.13	1.55∗	1.46–1.64
Age
20–30	1.00		1.00		1.00		1.00		1.00		1.00
31–40	1.10	0.90–1.34	1.07	0.89–1.29	1.12	0.85–1.48	1.53∗	1.19–1.95	1.77∗	1.12–2.79	1.31	0.98–1.77
41–50	1.11	0.91–1.34	1.18	0.98–1.41	1.21	0.93–1.59	1.30∗	1.02–1.65	1.37	0.88–2.13	1.32	0.98–1.76
51–60	1.31∗	1.08–1.59	1.43∗	1.19–1.72	1.59∗	1.21–2.09	1.26	0.99–1.61	1.27	0.82–1.98	1.44∗	1.07–1.92
61–70	1.62∗	1.33–1.97	1.71∗	1.42–2.06	2.04∗	1.55–2.69	1.36∗	1.06–1.73	1.14	0.72–1.79	2.03∗	1.51–2.72
71–80	1.99∗	1.62–2.45	1.71∗	1.41–2.08	2.07∗	1.55–2.76	1.86∗	1.44–2.41	1.55	0.96–2.49	2.39∗	1.76–3.25
> = 81	2.59∗	2.01–3.34	1.87∗	1.47–2.37	2.03∗	1.42–2.90	2.16∗	1.58–2.94	1.18	0.67–2.10	3.48∗	2.45–4.95
Residential area
Northern	1.00		1.00		1.00		1.00		1.00		1.00
Central	0.44∗	0.36–0.54	0.90	0.74–1.08	0.88	0.67–1.17	0.46∗	0.35–0.59	0.25∗	0.16–0.41	0.47∗	0.35–0.62
Southern	0.49∗	0.40–0.60	0.99	0.82–1.19	0.96	0.72–1.27	0.47∗	0.36–0.61	0.22∗	0.13–0.35	0.52∗	0.39–0.69
Eastern	0.51∗	0.42–0.63	1.00	0.83–1.21	0.97	0.73–1.30	0.54∗	0.41–0.70	0.29∗	0.18–0.48	0.40∗	0.30–0.54
CCI score
CCI = 0	1.00		1.00		1.00		1.00		1.00		1.00
CCI = 1	1.97∗	1.86–2.08	1.93∗	1.83–2.04	2.39∗	2.21–2.59	1.33∗	1.24–1.43	1.51∗	1.32–1.73	1.45∗	1.34–1.57
CCI≥2	3.09∗	2.81–3.39	2.29∗	2.09–2.50	2.99∗	2.62–3.41	2.28∗	2.02–2.57	3.43∗	2.73–4.30	2.29∗	2.01–2.60